annual CFI:
-$854.20M-$724.13M(-556.72%)Summary
- As of today (July 27, 2025), RNA annual cash flow from investing activities is -$854.20 million, with the most recent change of -$724.13 million (-556.72%) on December 31, 2024.
- During the last 3 years, RNA annual CFI has fallen by -$771.68 million (-935.18%).
- RNA annual CFI is now -1743167.35% below its all-time high of -$49.00 thousand, reached on December 31, 2018.
Performance
RNA Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$157.19M+$221.36M(+344.95%)Summary
- As of today (July 27, 2025), RNA quarterly cash flow from investing activities is $157.19 million, with the most recent change of +$221.36 million (+344.95%) on March 31, 2025.
- Over the past year, RNA quarterly CFI has increased by +$189.94 million (+580.01%).
- RNA quarterly CFI is now at all-time high.
Performance
RNA quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$664.27M+$189.94M(+22.24%)Summary
- As of today (July 27, 2025), RNA TTM cash flow from investing activities is -$664.27 million, with the most recent change of +$189.94 million (+22.24%) on March 31, 2025.
- Over the past year, RNA TTM CFI has dropped by -$697.13 million (-2121.32%).
- RNA TTM CFI is now -2121.32% below its all-time high of $32.86 million, reached on March 31, 2024.
Performance
RNA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RNA Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -556.7% | +580.0% | -2121.3% |
| 3 y3 years | -935.2% | +189.6% | -158.0% |
| 5 y5 years | -10000.0% | +10000.0% | -10000.0% |
RNA Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -935.2% | at low | at high | +132.6% | -2121.3% | +22.2% |
| 5 y | 5-year | <-9999.0% | at low | at high | +132.6% | -2121.3% | +22.2% |
| alltime | all time | <-9999.0% | at low | at high | +132.6% | -2121.3% | +22.2% |
RNA Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $157.19M(-344.9%) | -$664.27M(-22.2%) |
| Dec 2024 | -$854.20M(+556.7%) | -$64.17M(-86.7%) | -$854.20M(+15.6%) |
| Sep 2024 | - | -$482.41M(+75.5%) | -$738.99M(+156.5%) |
| Jun 2024 | - | -$274.87M(+739.4%) | -$288.06M(-976.5%) |
| Mar 2024 | - | -$32.75M(-164.2%) | $32.86M(-125.3%) |
| Dec 2023 | -$130.07M(-31.5%) | $51.04M(-262.1%) | -$130.07M(-31.1%) |
| Sep 2023 | - | -$31.48M(-168.4%) | -$188.88M(+29.0%) |
| Jun 2023 | - | $46.05M(-123.5%) | -$146.47M(-30.3%) |
| Mar 2023 | - | -$195.68M(+2419.1%) | -$210.16M(+10.6%) |
| Dec 2022 | -$189.96M(+130.2%) | -$7.77M(-171.1%) | -$189.96M(-28.7%) |
| Sep 2022 | - | $10.93M(-162.0%) | -$266.25M(-4.2%) |
| Jun 2022 | - | -$17.64M(-89.9%) | -$277.98M(+8.0%) |
| Mar 2022 | - | -$175.47M(+108.7%) | -$257.47M(+212.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$82.52M(+959.9%) | -$84.06M(>+9900.0%) | -$82.52M(+1432.9%) |
| Sep 2021 | - | -$800.00K(-127.9%) | -$5.38M(-0.8%) |
| Jun 2021 | - | $2.87M(-647.0%) | -$5.43M(-34.6%) |
| Mar 2021 | - | -$525.00K(-92.4%) | -$8.30M(+6.6%) |
| Dec 2020 | -$7.79M(+3212.8%) | -$6.93M(+720.1%) | -$7.79M(+722.9%) |
| Sep 2020 | - | -$845.00K(<-9900.0%) | -$946.00K(+722.6%) |
| Jun 2020 | - | $0.00(-100.0%) | -$115.00K(-53.1%) |
| Mar 2020 | - | -$10.00K(-89.0%) | -$245.00K(+4.3%) |
| Dec 2019 | -$235.00K(+379.6%) | -$91.00K(+550.0%) | -$235.00K(+63.2%) |
| Sep 2019 | - | -$14.00K(-89.2%) | -$144.00K(+10.8%) |
| Jun 2019 | - | -$130.00K(<-9900.0%) | -$130.00K(<-9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | -$49.00K | - | - |
FAQ
- What is Avidity Biosciences, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. annual CFI year-on-year change?
- What is Avidity Biosciences, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. quarterly CFI year-on-year change?
- What is Avidity Biosciences, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. TTM CFI year-on-year change?
What is Avidity Biosciences, Inc. annual cash flow from investing activities?
The current annual CFI of RNA is -$854.20M
What is the all time high annual CFI for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high annual cash flow from investing activities is -$49.00K
What is Avidity Biosciences, Inc. annual CFI year-on-year change?
Over the past year, RNA annual cash flow from investing activities has changed by -$724.13M (-556.72%)
What is Avidity Biosciences, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of RNA is $157.19M
What is the all time high quarterly CFI for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high quarterly cash flow from investing activities is $157.19M
What is Avidity Biosciences, Inc. quarterly CFI year-on-year change?
Over the past year, RNA quarterly cash flow from investing activities has changed by +$189.94M (+580.01%)
What is Avidity Biosciences, Inc. TTM cash flow from investing activities?
The current TTM CFI of RNA is -$664.27M
What is the all time high TTM CFI for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high TTM cash flow from investing activities is $32.86M
What is Avidity Biosciences, Inc. TTM CFI year-on-year change?
Over the past year, RNA TTM cash flow from investing activities has changed by -$697.13M (-2121.32%)